FT
XBI icon

Fiduciary Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fiduciary Trust’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.46M Sell
34,902
-205
-0.6% -$25.6K 0.05% 180
2025
Q4 		$4.28M Sell
35,107
-647
-2% -$74.2K 0.05% 191
2025
Q3 		$3.58M Sell
35,754
-929
-3% -$83.7K 0.04% 213
2025
Q2 		$3.04M Sell
36,683
-4,549
-11% -$363K 0.04% 225
2025
Q1 		$3.34M Sell
41,232
-2,699
-6% -$241K 0.04% 210
2024
Q4 		$3.96M Sell
43,931
-547
-1% -$53K 0.05% 187
2024
Q3 		$4.39M Sell
44,478
-579
-1% -$56.9K 0.06% 181
2024
Q2 		$4.18M Sell
45,057
-748
-2% -$67.1K 0.06% 173
2024
Q1 		$4.35M Sell
45,805
-701
-2% -$65K 0.07% 166
2023
Q4 		$4.15M Sell
46,506
-2,367
-5% -$176K 0.07% 163
2023
Q3 		$3.57M Sell
48,873
-4,067
-8% -$325K 0.07% 173
2023
Q2 		$4.4M Sell
52,940
-858
-2% -$71.8K 0.08% 157
2023
Q1 		$4.1M Sell
53,798
-997
-2% -$82.7K 0.08% 164
2022
Q4 		$4.55M Sell
54,795
-912
-2% -$73.8K 0.09% 158
2022
Q3 		$4.42M Sell
55,707
-520
-0.9% -$43.8K 0.1% 152
2022
Q2 		$4.18M Sell
56,227
-2,704
-5% -$203K 0.09% 161
2022
Q1 		$5.3M Sell
58,931
-2,800
-5% -$259K 0.1% 155
2021
Q4 		$6.91M Sell
61,731
-15
-0% -$1.81K 0.11% 143
2021
Q3 		$7.76M Sell
61,746
-2,060
-3% -$265K 0.14% 128
2021
Q2 		$8.64M Sell
63,806
-223
-0.3% -$29.3K 0.17% 120
2021
Q1 		$8.69M Sell
64,029
-338
-0.5% -$50.6K 0.18% 113
2020
Q4 		$9.06M Buy
64,367
+1,284
+2% +$164K 0.19% 102
2020
Q3 		$7.03M Sell
63,083
-750
-1% -$84.1K 0.17% 113
2020
Q2 		$7.15M Sell
63,833
-130
-0.2% -$12.8K 0.18% 106
2020
Q1 		$4.95M Sell
63,963
-399
-0.6% -$35.3K 0.14% 121
2019
Q4 		$6.12M Sell
64,362
-505
-0.8% -$43.7K 0.14% 123
2019
Q3 		$4.95M Sell
64,867
-2,869
-4% -$238K 0.12% 130
2019
Q2 		$5.94M Sell
67,736
-1,611
-2% -$137K 0.16% 111
2019
Q1 		$6.28M Sell
69,347
-535
-0.8% -$45.5K 0.17% 109
2018
Q4 		$5.01M Sell
69,882
-975
-1% -$78.6K 0.15% 108
2018
Q3 		$6.79M Sell
70,857
-950
-1% -$92.1K 0.19% 104
2018
Q2 		$6.83M Sell
71,807
-843
-1% -$77.5K 0.21% 103
2018
Q1 		$6.37M Sell
72,650
-1,725
-2% -$157K 0.2% 104
2017
Q4 		$6.31M Sell
74,375
-860
-1% -$72K 0.19% 106
2017
Q3 		$6.51M Sell
75,235
-2,572
-3% -$206K 0.2% 105
2017
Q2 		$6M Sell
77,807
-1,375
-2% -$97.5K 0.18% 110
2017
Q1 		$5.49M Sell
79,182
-5,897
-7% -$396K 0.17% 111
2016
Q4 		$5.04M Buy
85,079
+7,856
+10% +$485K 0.16% 114
2016
Q3 		$5.12M Sell
77,223
-1,764
-2% -$109K 0.18% 115
2016
Q2 		$4.27M Sell
78,987
-750
-0.9% -$41.1K 0.15% 127
2016
Q1 		$4.12M Buy
79,737
+113
+0.1% +$5.87K 0.15% 129
2015
Q4 		$5.59M Sell
79,624
-1,458
-2% -$99.4K 0.24% 96
2015
Q3 		$5.05M Sell
81,082
-5,735
-7% -$452K 0.23% 96
2015
Q2 		$7.3M Sell
86,817
-6,681
-7% -$520K 0.3% 82
2015
Q1 		$7.03M Buy
93,498
+120
+0.1% +$8.38K 0.29% 84
2014
Q4 		$5.8M Sell
93,378
-759
-0.8% -$43.3K 0.24% 93
2014
Q3 		$4.89M Sell
94,137
-2,688
-3% -$137K 0.22% 97
2014
Q2 		$4.97M Sell
96,825
-4,026
-4% -$182K 0.21% 98
2014
Q1 		$4.79M Sell
100,851
-10,689
-10% -$547K 0.21% 97
2013
Q4 		$4.84M Buy
111,540
+1,314
+1% +$54.4K 0.21% 95
2013
Q3 		$4.75M Sell
110,226
-4,182
-4% -$169K 0.22% 96
2013
Q2 		$3.98M Buy
+114,408
New +$4.02M 0.18% 102

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fiduciary Trust's XBI Position: Q1 2026 in Review

Fiduciary Trust reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.58% in Q1 2026, selling an estimated $25.6K and leaving 34,902 shares worth $4.46M. The position accounts for 0.05% of the portfolio, ranked #180.

Fiduciary Trust first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.06M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Fiduciary Trust held 34,902 shares of State Street SPDR S&P Biotech ETF worth $4.46M as of Q1 2026.
  • Fiduciary Trust sold 205 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $25.6K.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Fiduciary Trust's portfolio in Q1 2026, its #180 holding.
  • Fiduciary Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's State Street SPDR S&P Biotech ETF position peaked at $9.06M in Q4 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.